article thumbnail

Digiceuticals: Driving Growth Through Digital Health Services

HIT Consultant

Subhro Mallik, SVP & Head of Life Sciences at Infosys. The new normal has thrown up opportunities as well as risks for pharmaceutical companies. The application of digital technologies in pharmaceuticals – digiceuticals – is a promising way forward. There was tremendous interest in telemedicine before 2020.

article thumbnail

HeartMates, Bringing Community and Heart Health Love from Damar Hamlin – Abbott at #CES2024

Health Populi

Abbott, one of the first life science companies to exhibit at CES back in 2022, announced the HeartMates program here at #CES2024 today as part of a panel titled Ahead of the Game: Revolutionizing Athlete Safety with Emerging Health Tech.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Linus Health Acquires Clinical-Grade Speech Platform Aural Analytics

HIT Consultant

The acquisition allows Linus Health to enter the life sciences market, offering its technology to pharmaceutical companies for use in drug development and clinical trials. Linus Health’s existing digital cognitive assessments, like the DCR™, will be enhanced by Aural Analytics’ speech analysis capabilities.

article thumbnail

Pharma & Influencer Marketing: Can They Coexist Ethically?

HIT Consultant

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. On the one hand, leveraging individual patients’ personal experiences and narratives may help bring an authentic voice to product messaging.

article thumbnail

Is making mRNA vaccines for infectious diseases profitable?

Healthcare ECONOMIST

The figure below shows that as the Delta and Omicron variants spread in the fall of 2021, COVID-19 vaccines prevented significant number of deaths according to Vox. Despite these positive impacts, a number of political commentators have accused pharmaceutical companies of profiteering. A study by Ahuja et al. A study by Ahuja et al.

article thumbnail

TRANSFORM Trial Unveiled: AI-Powered Approach for Personalized Heart Disease Care

HIT Consultant

This groundbreaking trial aims to revolutionize the way heart disease is prevented by evaluating a personalized care strategy based on Cleerly’s AI-powered coronary artery disease (CAD) plaque staging system. They will not receive a CAD plaque staging report.

article thumbnail

How Intelligent Document Processing (IDP) Revolutionizes Clinical Trials

HIT Consultant

Gary Shorter – Head, AI and Data Science, IQVIA Technologies In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.